Martin Levenson, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 480 Main St, Millis, MA 02054 Phone: 508-269-3232 |
Ms. Rachel Claire Schwartz, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3 Stoneybrook Dr Apt 4, Millis, MA 02054 Phone: 607-222-6346 |
Julia Casale Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Stoneybrook Dr Apt 1, Millis, MA 02054 Phone: 813-465-0080 |
Mr. Ferd Wilder, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 142 Exchange St, Millis, MA 02054 Phone: 508-376-6018 |
Meghan Dellorco, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23 Country Village Way, Millis, MA 02054 Phone: 508-446-4210 |
Elise Lafortune-molloy, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7 Park Rd, Millis, MA 02054 Phone: 508-376-7003 |
News Archive
University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy.
The mammography capacity nationwide is adequate, but some area shortages, in both the number of facilities and medical personnel, might make it difficult for some women to undergo the procedure, according to a Government Accountability Office report released Wednesday, CQ HealthBeat reports (Carey, CQ HealthBeat, 8/16).
Guidelines for teenagers should stress the importance of vigorous physical activity and fitness to cut the risk of heart disease, new research suggests. Current NHS guidelines say people aged 5 to 18 should do at least 60 minutes of moderate to vigorous physical activity each day to improve their current and future health.
Male and female rats show different patterns of kidney gene expression throughout their lives, a study in the open access journal Biology of Sex Differences reveals. The finding could help explain some of the gender differences observed in human renal disease, and lead to improved biomarkers of kidney function.
Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis.
› Verified 5 days ago